Use the hyperlinks, where available to access additional clinical trial information.
The NINJA Clinical Trial: Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation
Trans Tasman Radiation Oncology Group (TROG)
Mundipharma Research Limited
Other Non-Commercial Sponsor
Australian and New Zealand Urogenital and Prostate cancer trials group (ANZUP)
Patients eligible to participate in this study will receive radiation therapy, which will be delivered by one of two schedules. The first schedule will involve 40 Grays (Gy) of radiation delivered in five fractions 1-3 times per week. The second schedule will involve 20Gy in 2 fractions delivered once per week, followed by a two week break and 36Gy in 12 fractions, delivered 4-5 times per week. All patients will receive injections of androgen deprivation therapy for 6 months, commencing 3-4 months prior to radiation.